171 related articles for article (PubMed ID: 29904277)
1. miR-433 inhibits breast cancer cell growth via the MAPK signaling pathway by targeting Rap1a.
Zhang T; Jiang K; Zhu X; Zhao G; Wu H; Deng G; Qiu C
Int J Biol Sci; 2018; 14(6):622-632. PubMed ID: 29904277
[TBL] [Abstract][Full Text] [Related]
2. Role of miR-337-3p and its target Rap1A in modulating proliferation, invasion, migration and apoptosis of cervical cancer cells.
Cao XM
Cancer Biomark; 2019; 24(3):257-267. PubMed ID: 30883336
[TBL] [Abstract][Full Text] [Related]
3. miR-142-5p regulates pancreatic cancer cell proliferation and apoptosis by regulation of RAP1A.
Yao R; Xu L; Wei B; Qian Z; Wang J; Hui H; Sun Y
Pathol Res Pract; 2019 Jun; 215(6):152416. PubMed ID: 31047726
[TBL] [Abstract][Full Text] [Related]
4. MiR-203 down-regulates Rap1A and suppresses cell proliferation, adhesion and invasion in prostate cancer.
Xiang J; Bian C; Wang H; Huang S; Wu D
J Exp Clin Cancer Res; 2015 Jan; 34(1):8. PubMed ID: 25636908
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-340 inhibits the migration, invasion, and metastasis of breast cancer cells by targeting Wnt pathway.
Mohammadi-Yeganeh S; Paryan M; Arefian E; Vasei M; Ghanbarian H; Mahdian R; Karimipoor M; Soleimani M
Tumour Biol; 2016 Jul; 37(7):8993-9000. PubMed ID: 26758430
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-335 suppresses the proliferation, migration, and invasion of breast cancer cells by targeting EphA4.
Dong Y; Liu Y; Jiang A; Li R; Yin M; Wang Y
Mol Cell Biochem; 2018 Feb; 439(1-2):95-104. PubMed ID: 28795314
[TBL] [Abstract][Full Text] [Related]
7. Knockdown of miR-194-5p inhibits cell proliferation, migration and invasion in breast cancer by regulating the Wnt/β-catenin signaling pathway.
Yang F; Xiao Z; Zhang S
Int J Mol Med; 2018 Dec; 42(6):3355-3363. PubMed ID: 30272253
[TBL] [Abstract][Full Text] [Related]
8. Tumor-promoting properties of miR-8084 in breast cancer through enhancing proliferation, suppressing apoptosis and inducing epithelial-mesenchymal transition.
Gao Y; Ma H; Gao C; Lv Y; Chen X; Xu R; Sun M; Liu X; Lu X; Pei X; Li P
J Transl Med; 2018 Feb; 16(1):38. PubMed ID: 29471858
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of miR-660-5p expression suppresses tumor development and metastasis in human breast cancer.
Shen Y; Ye YF; Ruan LW; Bao L; Wu MW; Zhou Y
Genet Mol Res; 2017 Feb; 16(1):. PubMed ID: 28252173
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-188-5p promotes apoptosis and inhibits cell proliferation of breast cancer cells via the MAPK signaling pathway by targeting Rap2c.
Zhu X; Qiu J; Zhang T; Yang Y; Guo S; Li T; Jiang K; Zahoor A; Deng G; Qiu C
J Cell Physiol; 2020 Mar; 235(3):2389-2402. PubMed ID: 31541458
[TBL] [Abstract][Full Text] [Related]
11. MiR-196a binding-site SNP regulates RAP1A expression contributing to esophageal squamous cell carcinoma risk and metastasis.
Wang K; Li J; Guo H; Xu X; Xiong G; Guan X; Liu B; Li J; Chen X; Yang K; Bai Y
Carcinogenesis; 2012 Nov; 33(11):2147-54. PubMed ID: 22859270
[TBL] [Abstract][Full Text] [Related]
12. MiR-410 Acts as a Tumor Suppressor in Estrogen Receptor-Positive Breast Cancer Cells by Directly Targeting ERLIN2 via the ERS Pathway.
Wu H; Li J; Guo E; Luo S; Wang G
Cell Physiol Biochem; 2018; 48(2):461-474. PubMed ID: 30016800
[TBL] [Abstract][Full Text] [Related]
13. Long noncoding RNA SNHG15 promotes human breast cancer proliferation, migration and invasion by sponging miR-211-3p.
Kong Q; Qiu M
Biochem Biophys Res Commun; 2018 Jan; 495(2):1594-1600. PubMed ID: 29217194
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-145 inhibits growth and migration of breast cancer cells through targeting oncoprotein ROCK1.
Zheng M; Sun X; Li Y; Zuo W
Tumour Biol; 2016 Jun; 37(6):8189-96. PubMed ID: 26715279
[TBL] [Abstract][Full Text] [Related]
15. MiRNA-183-5p promotes cell proliferation and inhibits apoptosis in human breast cancer by targeting the PDCD4.
Cheng Y; Xiang G; Meng Y; Dong R
Reprod Biol; 2016 Sep; 16(3):225-233. PubMed ID: 27476679
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-494 inhibits breast cancer progression by directly targeting PAK1.
Zhan MN; Yu XT; Tang J; Zhou CX; Wang CL; Yin QQ; Gong XF; He M; He JR; Chen GQ; Zhao Q
Cell Death Dis; 2017 Jan; 8(1):e2529. PubMed ID: 28055013
[TBL] [Abstract][Full Text] [Related]
17. MiR-203 involves in neuropathic pain development and represses Rap1a expression in nerve growth factor differentiated neuronal PC12 cells.
Li H; Huang Y; Ma C; Yu X; Zhang Z; Shen L
Clin J Pain; 2015 Jan; 31(1):36-43. PubMed ID: 24451631
[TBL] [Abstract][Full Text] [Related]
18. MiR-15a is underexpressed and inhibits the cell cycle by targeting CCNE1 in breast cancer.
Luo Q; Li X; Li J; Kong X; Zhang J; Chen L; Huang Y; Fang L
Int J Oncol; 2013 Oct; 43(4):1212-8. PubMed ID: 23900351
[TBL] [Abstract][Full Text] [Related]
19. In vivo and in vitro effects of microRNA-27a on proliferation, migration and invasion of breast cancer cells through targeting of SFRP1 gene via Wnt/β-catenin signaling pathway.
Kong LY; Xue M; Zhang QC; Su CF
Oncotarget; 2017 Feb; 8(9):15507-15519. PubMed ID: 28099945
[TBL] [Abstract][Full Text] [Related]
20. Suppression of SPIN1-mediated PI3K-Akt pathway by miR-489 increases chemosensitivity in breast cancer.
Chen X; Wang YW; Xing AY; Xiang S; Shi DB; Liu L; Li YX; Gao P
J Pathol; 2016 Aug; 239(4):459-72. PubMed ID: 27171498
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
